Search
for
Sort by
Research 61–90 of 1000+
- Medical treatment regimens of hirsutism
- COVID‐19, androgens, and androgenic alopecia
- Endocannabinoid activation and polycystic ovary syndrome: A systematic review
- Association of androgenetic alopecia and severity of coronavirus disease 2019
- The role of testosterone in SARS-CoV-2 infection
- Polycystic Ovary Syndrome
- Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care
- Androgenic alopecia--Its characteristics and perspectives
- Adult polycystic ovary syndrome begins in childhood
- Medical treatment of hirsutism
- Therapeutic options in the polycystic ovary syndrome
- Hirsutism: Diagnosis and Treatment
- Understanding polycystic ovary syndrome
- CURRENT THERAPEUTIC APPROACHES IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME
- Management of Polycystic Ovarian Syndrome: Looking Beyond the Ovaries
- PERAN KELENJAR SEBASEA PADA ALOPESIA ANDROGENIK
- Update on nail disorders
- Metabolic syndrome
- Androgen Induction of Follicular Epithelial Cell Growth Is Mediated via Insulin-like Growth Factor-I from Dermal Papilla Cells
- Principles of management of women with hirsutism – a dermatologist’s perspective
- THERAPEUTIC APPROACHES TO THE MANAGEMENT OF COMMON BALDNESS
- Comprehensive Strategies for the Management of Androgenetic Alopecia: From Conventional Therapies to Nanotechnology and Regenerative Approaches
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Antiandrogens and Androgen Inhibitors
- Optimal use of topical minoxidil in management of female pattern hair loss in India: an expert opinion
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis
- Therapeutic strategies for treating hair loss
- Biotechs target stagnant baldness market
- Antiandrogens